Summary
McMaster University is soliciting bids from qualified suppliers for the supply of PET and SPECT preclinical imaging systems that will be used by the newly established McMaster Institute for Radiopharmaceutical Imaging and Therapy (MIRIT). The systems must perform quantitative imaging and dosimetry for therapeutic isotopes such as Lu-177 and Tb-161 on live animals (rats, mice), supporting McMaster's radiopharmaceutical and theranostics research program across oncology, neurology, cardiology, and inflammation. This is a one-time purchase including a one-year warranty with optional additional warranty and service of up to three years, with delivery to McMaster University in Hamilton, Ontario required by July 31, 2026.